戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ER2 (apolipoprotein E receptor 2) and VLDLR (very-low-density lipoprotein receptor).
2 (d), approximately 30 nM) but not to soluble very low density lipoprotein receptor.
3 e gene expression for lipoprotein lipase and very-low-density lipoprotein receptor.
4 rs, apolipoprotein E receptor 2 (Apoer2) and very-low-density lipoprotein receptor.
5 s cortical layering by signaling through the very low density lipoprotein receptor and apolipoprotein
6 orylated form in mice lacking Reelin or both very low density lipoprotein receptor and apolipoprotein
7 ons for two LDL receptor family members, the very low density lipoprotein receptor and the apoE recep
8 eted extracellular protein that binds to the very low density lipoprotein receptor and the apolipopro
9 gnaling pathway that requires its receptors, very low-density lipoprotein receptor and apolipoprotein
10 by binding to the two lipoprotein receptors, very-low-density lipoprotein receptor and apolipoprotein
11  Reelin that is not mediated by Disabled1 or very-low-density lipoprotein receptors and apolipoprotei
12 y, including the receptors ApoER2 and VLDLR (very low density lipoprotein receptor) and the adapter p
13 is dependent on apolipoprotein E receptor 2, very low density lipoprotein receptor, and Dab1.
14 ily, the apolipoprotein E receptor 2 and the very low density lipoprotein receptor, and regulates neu
15 eceptors for Reelin, including integrins and very-low-density lipoprotein receptor/apolipoprotein E2
16 ransfer experiments, we demonstrate that the very low density lipoprotein receptor can also bind and
17 r domains of apolipoprotein E receptor 2 and very low density lipoprotein receptor, Dab1 is preferent
18 l mouse models of retinal blood leakage, the very-low-density-lipoprotein receptor deficient mouse (V
19 l blood vessels invading photoreceptors: the very low-density lipoprotein receptor-deficient (Vldlr(-
20                                              Very low density lipoprotein receptor gene knock-out (Vl
21 the likelihood that this polymorphism in the very-low-density lipoprotein receptor gene is strongly a
22 rgets proteins involved in lipid metabolism (very low-density lipoprotein receptor), immunity (major
23  We determined the allele frequencies of the very-low-density lipoprotein receptor in 3 white populat
24  region of an apolipoprotein E receptor, the very-low-density lipoprotein receptor, is genetically as
25 ation and vascular leakage in the eyecups of very low-density lipoprotein receptor knockout mice, a m
26 creases low-density lipoprotein receptor and very low-density lipoprotein receptor levels via an extr
27                                              Very low-density lipoprotein receptor mutant mice (Vldlr
28 a with plasminogen activator inhibitor 1 and very low-density lipoprotein receptor on HUVEC or HAEC s
29 ells via apolipoprotein E receptor 2 and the very low density lipoprotein receptor, resulting in the
30 ptor proteins, apolipoprotein receptor 2 and very low density lipoprotein receptor, results in a Reln
31            Previously, we identified soluble very low-density lipoprotein receptor (sVLDLR) as an end
32 an interaction with the RELN receptor VLDLR (very low-density lipoprotein receptor); this was confirm
33 ails of the lipoprotein receptors ApoER2 and very low density lipoprotein receptor through an amino-t
34 runcated TFPI molecule, is recognized by the very low density lipoprotein receptor (VLDL receptor) in
35  the LDL receptor-related protein (LRP), the very low density lipoprotein receptor (VLDL), and apoE r
36                                          The very low density lipoprotein receptor (VLDL-R) binds and
37 rototype of this family, which also contains very-low-density lipoprotein receptors (VLDL-R), apolipo
38                                Activation of very low density lipoprotein receptor (VLDLR) and apolip
39 Reelin signals via the lipoprotein receptors very low density lipoprotein receptor (VLDLR) and apolip
40 ther proteins, cell surface receptors termed very low density lipoprotein receptor (VLDLR) and apolip
41  to apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and is int
42      We discovered that miR-200c targets the very low density lipoprotein receptor (Vldlr) and its li
43                            For instance, the very low density lipoprotein receptor (VLDLR) and the ap
44 lves two neuronal cell surface proteins, the very low density lipoprotein receptor (VLDLR) and the ap
45             ApoE Receptor 2 (ApoER2) and the very low density lipoprotein receptor (VLDLR) are type I
46                                          The very low density lipoprotein receptor (VLDLr) binds dive
47 ransfer to study the in vivo function of the very low density lipoprotein receptor (VLDLR) in low den
48                                          The very low density lipoprotein receptor (VLDLR) is a membe
49               Previously, we have shown that very low density lipoprotein receptor (VLDLR) is virtual
50  include the LDLR-related protein (LRP), the very low density lipoprotein receptor (VLDLR), the apoli
51 migrating cortical neurons by binding to the very low density lipoprotein receptor (VLDLR), the apoli
52 induced choroidal neovascularization and the very low density lipoprotein receptor (Vldlr)-knockout m
53 red the cooperative function of uPAR and the very low density lipoprotein receptor (VLDLr).
54 le seven-module cluster, vertebrate VgRs and very low density lipoprotein receptors (VLDLR) which hav
55 tly to lipoprotein receptors, preferably the very low-density lipoprotein receptor (VLDLR) and apolip
56 ion to binding human PCDH10, could also bind very low-density lipoprotein receptor (VLDLR) and apolip
57 nt in Reelin, Disabled 1 (Dab1), or both the very low-density lipoprotein receptor (VLDLR) and the ap
58                         Here we identify the very low-density lipoprotein receptor (VLDLR) as a recep
59                                              Very low-density lipoprotein receptor (VLDLR) is a multi
60                                          The very low-density lipoprotein receptor (VLDLR) knockout (
61 le pathways including through the receptors, Very low-density lipoprotein receptor (Vldlr), Apolipopr
62   Mice deficient in another Reelin receptor, very low-density lipoprotein receptor (VLDLR), had norma
63 r class A domain-containing 3 (LDLRAD3), and very low-density lipoprotein receptor (VLDLR), which fac
64 mily members as well, including LRP2 and the very low-density lipoprotein receptor (VLDLR).
65 ors apolipoprotein E receptor 2 (Apoer2) and very low-density lipoprotein receptor (Vldlr).
66                       We recently identified very-low density lipoprotein receptor (VLDLR) and apolip
67 engagement for two of their entry receptors: very-low-density lipoprotein receptor (VLDLR) and protoc
68 ng embryonic neurons requires binding to the very-low-density lipoprotein receptor (VLDLR) and the ap
69                                          The very-low-density lipoprotein receptor (VLDLR) comprises
70 revealed a point mutation, c.2239C>T, in the very-low-density lipoprotein receptor (Vldlr) gene.
71                                              Very-low-density lipoprotein receptor (VLDLR) in knockou
72                                              Very-low-density lipoprotein receptor (VLDLR) is a multi
73                                          The very-low-density lipoprotein receptor (VLDLR) negatively
74 orted to be critical for binding EEEV to the very-low-density lipoprotein receptor (VLDLR), an EEEV r
75                                              Very-low-density lipoprotein receptor (Vldlr), which is
76  retinopathy and another angiogenic model of very-low-density lipoprotein receptor (Vldlr)-deficient
77 und to human PCDH10, avian PCDH10, and human very-low-density lipoprotein receptor (VLDLR).
78  the brain involves the binding of Reelin to very-low-density lipoprotein receptors (VLDLR) and apoli
79 scular entothelial growth factor [VEGF], and very low density lipoprotein receptor [VLDLR]) were test
80 induced CNV or mice with a deficiency in the very low-density lipoprotein receptor), we found that de
81 uncation disrupts an interaction with VLDLR (very low-density lipoprotein receptor), while the APOER2